Brief: Ardelyx Collaboration Partner, Kyowa Kirin, Announces Submission Of New Drug Application For Tenapanor For Hyperphosphatemia In Japan
31/10/2022 12:25
Oct 31 (Reuters) - Kyowa Kirin Co Ltd 4151.T :
* ARDELYX COLLABORATION PARTNER, KYOWA KIRIN, ANNOUNCES
SUBMISSION
OF NEW DRUG APPLICATION FOR TENAPANOR FOR HYPERPHOSPHATEMIA IN
JAPAN
* ARDELYX INC - TO RECEIVE AN AGGREGATE OF $35 MILLION IN
MILESTONE PAYMENTS AND PAYMENTS ASSOCIATED WITH RECENT AMENDMENT
OF LICENSE AGREEMENT
Source text for Eikon: ID:nPn5r673da
Further company coverage: 4151.T
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia